FindTrial
Sign In

The clinical outcome of controlled ovarian stimulation using Utrogestan and HMG in women with PCOS: a prospective, randomized, controlled trial

The clinical outcome of controlled ovarian stimulation using Utrogestan and HMG in women with PCOS: a prospective, randomized, controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-15006633
Enrollment
Unknown
Registered
2015-06-21
Start date
2015-06-26
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infertility

Interventions

Group A:Utrogestan protocol
Group B:Antagonist protocol

Sponsors

Shanghai Ninth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: infertility women, aged 20-40 years,PCOS

Exclusion criteria

Exclusion criteria: clinically significant systemic disease such as renal failure, endometrosis grade 3 or higher, any contraindications to ovarian stimulation treatment and documented poor ovarian response.

Design outcomes

Primary

MeasureTime frame
No. of oocytes retrieved;No.of mature oocytes;incidence of OHSS;occurrence of a premature LH surge;—

Secondary

MeasureTime frame
No.of viable embryo;pregnancy rate;—

Countries

China

Contacts

Public ContactYonglun Fu
fuyonglunivf@163.com+86 13917547302

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 15, 2026